Skip to content

Erythromycin EP Impurity I

Erythromycin EP Impurity I

Product Description
CAT No.
ALN-E006014
CAS No.
NA
Mol. F.
C29H49NO8
Mol. Wt.
539.7
Stock
Please Inquire
RFQ
Chemical Name : (1S,4S,5R,8R,9S,10S,11R,12R,14R)-5-ethyl-9-hydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec-2-en-7-one (as per EP)
Smiles : CN(C1CC(OC(OC(C2(CC3C)C)C(C)C(O)C(C(OC(C(C=C4C)(OC43O2)C)CC)=O)C)C1O)C)C
Synonym : Erythralosamine

Isolation and identification of a novel erythromycin-degrading fungus, Curvularia sp. RJJ-5, and its degradation pathway

By Ren, Jianjun; Deng, Liujie; Niu, Dongze; Wang, Zhenzhu; Fan, Bo; Taoli, Huhe; Li, Zhijie; Zhang, Jin; Li, ChunyunFrom FEMS Microbiology Letters (2021), 368(1), fnaa215.

Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets

By Jeelani, Salika; Soukhova, Nadejda – From Journal of Pharmaceutical and Biomedical Analysis (2021), 195, 113858

Degradation and mineralization of erythromycin by heterogeneous photocatalysis using SnO2-doped TiO2 structured catalysts: Activity and stability

By Albornoz, L. L.; da Silva, S. W.; Bortolozzi, J. P.; Banus, E. D.; Brussino, P.; Ulla, M. A.; Bernardes, A. M. – From Chemosphere (2021), 268, 128858

Request For Quotation

Related Products